NCT03253185View on ClinicalTrials.gov

A Study of SC-007 in Subjects With Advanced Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

September 13, 2017

Primary Completion Date

March 20, 2018

Study Completion Date

April 2, 2018

Conditions
Colorectal Cancer (CRC)Gastric Cancer
Interventions
DRUG

SC-007

intravenous

Trial Locations (7)

37203

Tennessee Oncology-Sarah Cannon Research Institute, Nashville

44718

Gabrail Cancer Center Research, Canton

63110

Washington University-School of Medicine, St Louis

77030

MD Anderson Cancer Center, Houston

78229

South Texas Accelerated Research Therapeutics, San Antonio

90095

University of California, Los Angeles, Los Angeles

55905-0001

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY